Rationale, design, and baseline characteristics of a trial for the prevention of diabetic atherosclerosis using a DPP-4 inhibitor: the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). (Q42614893)
Jump to navigation
Jump to search
scientific article published on 20 August 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Rationale, design, and baseline characteristics of a trial for the prevention of diabetic atherosclerosis using a DPP-4 inhibitor: the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). |
scientific article published on 20 August 2013 |
Statements
Rationale, design, and baseline characteristics of a trial for the prevention of diabetic atherosclerosis using a DPP-4 inhibitor: the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) (English)
Naoto Katakami
Tomoya Mita
Hidenori Yoshii
Tomio Onuma
Hideaki Kaneto
Takeshi Osonoi
Toshihiko Shiraiwa
Keisuke Kosugi
Yutaka Umayahara
Tsunehiko Yamamoto
Hiroki Yokoyama
Nobuichi Kuribayashi
Hideaki Jinnouchi
Masahiko Gosho
Iichiro Shimomura
Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis Trial